Home7R8 • FRA
add
Replimune Group Inc
Previous close
€3.80
Day range
€4.26 - €4.26
Year range
€2.30 - €15.00
Market cap
409.79M USD
Avg Volume
1.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 90.00M | 58.10% |
Net income | -86.69M | -61.22% |
Net profit margin | — | — |
Earnings per share | -0.95 | -21.79% |
EBITDA | -89.43M | -59.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 403.34M | -14.02% |
Total assets | 469.51M | -12.24% |
Total liabilities | 132.79M | 22.37% |
Total equity | 336.72M | — |
Shares outstanding | 78.06M | — |
Price to book | 0.88 | — |
Return on assets | -44.08% | — |
Return on capital | -49.72% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -86.69M | -61.22% |
Cash from operations | -77.02M | -56.64% |
Cash from investing | 65.05M | 118.53% |
Cash from financing | -158.00K | -100.16% |
Net change in cash | -13.74M | -117.80% |
Free cash flow | -51.41M | -64.57% |
About
Founded
2015
Headquarters
Website
Employees
479